Compositions and methods for modulating metabolic pathways
First Claim
Patent Images
1. A composition comprising:
- (a) at least 500 mg of leucine and/or at least 200 mg of one or more metabolites thereof, wherein the one or more leucine metabolites are selected from the group consisting of keto-isocaproic acid (KIC), alpha-hydroxy-isocaproic acid, and HMB; and
(b) at least 1 mg of a sirtuin pathway activator that is an anti-diabetic agent selected from the group consisting of a dipeptidyl peptidase (DPP) inhibitor, incretin and/or incretin mimetic;
wherein the composition is substantially free of the individual amino acids alanine, glutamic acid, glycine, isoleucine, valine, and proline;
wherein the composition is formulated as a tablet, capsule, gel capsule, beverage, snack bar or a food composition;
wherein when (a) is a metabolite of leuine the molar ratio of (a) to (b) is greater than 10; and
wherein when (a) is leucine, the molar ratio of (a) to (b) is greater than 500.
2 Assignments
0 Petitions
Accused Products
Abstract
Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.
-
Citations
26 Claims
-
1. A composition comprising:
- (a) at least 500 mg of leucine and/or at least 200 mg of one or more metabolites thereof, wherein the one or more leucine metabolites are selected from the group consisting of keto-isocaproic acid (KIC), alpha-hydroxy-isocaproic acid, and HMB; and
(b) at least 1 mg of a sirtuin pathway activator that is an anti-diabetic agent selected from the group consisting of a dipeptidyl peptidase (DPP) inhibitor, incretin and/or incretin mimetic;
wherein the composition is substantially free of the individual amino acids alanine, glutamic acid, glycine, isoleucine, valine, and proline;
wherein the composition is formulated as a tablet, capsule, gel capsule, beverage, snack bar or a food composition;
wherein when (a) is a metabolite of leuine the molar ratio of (a) to (b) is greater than 10; and
wherein when (a) is leucine, the molar ratio of (a) to (b) is greater than 500. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)
- (a) at least 500 mg of leucine and/or at least 200 mg of one or more metabolites thereof, wherein the one or more leucine metabolites are selected from the group consisting of keto-isocaproic acid (KIC), alpha-hydroxy-isocaproic acid, and HMB; and
Specification